Skip to main content


Onychomycosis is a chronic fungal infection of the toenails and/or fingernails that has a global prevalence in children of 0.35 to 5.5 percent.1 Approximately 15 percent of all nail dystrophies in children are due to onychomycosis.2 Though less…

By Jennifer Spector, DPM, FACFAS, Associate Editor

Could an innovative technology help improve patient outcomes for onychomycosis and increase practice revenue?

The PinPointe™ FootLaser® is a Food and Drug Administration (FDA)-cleared system for temporary increase of clear nail in…

In my opinion, onychomycosis is a cosmetic concern. Rarely does a patient with nail fungus have pain. Most often, patients with nail fungus present to the office with the concern of a thickened and discolored nail that is unsightly, or patients…

Urea has long been an effective and safe treatment modality for numerous dermatologic disorders. The use of urea for the management of damaged, devitalized, dystrophic and mycotic nails is well documented.1 The mechanism of action of urea in the…

Keith Sklar, DPM, FACFAS

Emphasizing the treatment of onychomycosis as an infection and a cosmetic problem, this author offers insights from his experience with a synergistic management protocol and provides several case studies.

Brian McCurdy, Managing Editor

Two recent phase III studies point to a new topical agent as an effective treatment option for onychomycosis.

Dr. Vlahovic, I read with interest your feature article, “Current and Emerging Agents for Tinea Pedis,” in the April 2014 issue of Podiatry Today.

Back to Top